This week, I’m going to focus on the Price to Sales ratio for finding great stocks at great values. The Price to Sales ratio is a great valuation metric. And given the recent run-up in stocks, value, to me, is becoming more and more important. In fact, aside from the Zacks Rank, if I could…
The end of the year is once again in sight and that is why we are eager to look forward to next year already. We want to line up the things you will need to be taking into account next year as an investor. Don’t go telling you were not warned. First, you will need…
We are still a few weeks away from the Q4 earnings season, but companies with fiscal quarters ending in November will also form part of the Q4 reporting cycle. The AutoZone (AZO – Analyst Report) report this morning and the Adobe (ADBE – Analyst Report) report on Thursday all fall in that category of earnings…
The Chart of the Day belongs to Tribune Publishing (NYSE:TPUB). I found the stock by sorting the All Time High list for stocks hitting the most new highs in the last month. Barchart does not give ratings on stocks until they have been trading for at least 6 months so this one may be a…
Not sure what to make of today. The recovery didn’t look like one based on merit and will be vulnerable to early morning weakness. The Russell 2000 went from trading range support to resistance as it finished with a bullish engulfing pattern. The strength of the pattern is weakened by the lack of oversold conditions….
Curious how over the past 6 years we got to a point where the market is now so irreparably broken, even the BIS couldn’t take it anymore and threw up all over the the world’s central bankers? Then look no further than the following chart summarizing 6 years of global central bank liquidity injections that…
How ever-loving stupid do they think we really are? Goldman’s plenipotentiary at the New York Fed, William Dudley or B-Dud, has been running around pointedly emitting a new word signal called “patient” rather than “considerable time” to describe the Fed’s interest raising plan. Then right on cue, his alter ego back at Goldman central, Herr Hatzius, yesterday dug…
I just returned home from the 20th Annual Global Indexing & ETFs Conference in Scottsdale, Arizona. Popular topics included moving beyond cap-weighted index funds, the growing search for yield and the increasing role of volatility in the management of risk. The conference organizers had asked me to participate on the volatility panel and the moderator…
Deals and Financings WuXi PharmaTech (NYSE: WX), China’s largest CRO/CMO, has filed to list its chemical manufacturing subsidiary, SynTheAll Pharmaceutical Co. Ltd., on China’s Third Board, a two-year old electronic OTC exchange (see story). Although it has submitted a listing application, WuXi said it may not conduct an IPO for STA immediately after approval. WuXi further explained…
As markets have been inching down on Tuesday, a particular stock took a pretty hard hit. After releasing its financial results for the third quarter, Conn’s, Inc. (NASDAQ:CONN) stock slid by 41% in intraday trading, making the company the top loser on Tuesday. As investors have been unloading shares, the trading volume amounting to more than…
